{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:56:05Z","timestamp":1787003765821,"version":"build-2736575974"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,12,20]],"date-time":"2023-12-20T00:00:00Z","timestamp":1703030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,12,20]],"date-time":"2023-12-20T00:00:00Z","timestamp":1703030400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Primary immunodeficiency (PI) is a group of heterogeneous disorders resulting from immune system defects. Over 70% of PI is undiagnosed, leading to increased mortality, co-morbidity and healthcare costs. Among PI disorders, combined immunodeficiencies (CID) are characterized by complex immune defects. Common variable immunodeficiency (CVID) is among the most common types of PI. In light of available treatments, it is critical to identify adult patients at risk for CID and CVID, before the development of serious morbidity and mortality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We developed a deep learning-based method (named \u201cTabMLPNet\u201d) to analyze clinical history from nationally representative medical claims from electronic health records (Optum\u00ae data, covering all US), evaluated in the setting of identifying CID\/CVID in adults. Further, we revealed the most important CID\/CVID-associated antecedent phenotype combinations. Four large cohorts were generated: a total of 47,660 PI cases and (1:1 matched) controls.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The sensitivity\/specificity of TabMLPNet modeling ranges from 0.82-0.88\/0.82-0.85 across cohorts. Distinctive combinations of antecedent phenotypes associated with CID\/CVID are identified, consisting of respiratory infections\/conditions, genetic anomalies, cardiac defects, autoimmune diseases, blood disorders and malignancies, which can possibly be useful to systematize the identification of CID and CVID.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>We demonstrated an accurate method in terms of CID and CVID detection evaluated on large-scale medical claims data. Our predictive scheme can potentially lead to the development of new clinical insights and expanded guidelines for identification of adult patients at risk for CID and CVID as well as be used to improve patient outcomes on population level.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1038\/s43856-023-00412-8","type":"journal-article","created":{"date-parts":[[2023,12,20]],"date-time":"2023-12-20T09:02:43Z","timestamp":1703062963000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Large-scale deep learning analysis to identify adult patients at risk for combined and common variable immunodeficiencies"],"prefix":"10.1038","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1939-296X","authenticated-orcid":false,"given":"Giorgos","family":"Papanastasiou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7344-7733","authenticated-orcid":false,"given":"Guang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitris I.","family":"Fotiadis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos","family":"Dikaios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengjia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahsan","family":"Huda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luba","family":"Sobolevsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Raasch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gurinder","family":"Sidhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna","family":"Palumbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,20]]},"reference":[{"key":"412_CR1","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s13223-018-0290-5","volume":"14","author":"C McCusker","year":"2018","unstructured":"McCusker, C., Upton, J. & Warrington, R. Primary immunodeficiency. Allergy Asthma Clin. Immunol. 14, 61 (2018).","journal-title":"Allergy Asthma Clin. Immunol."},{"key":"412_CR2","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.jaut.2019.01.011","volume":"99","author":"L Amaya-Uribe","year":"2019","unstructured":"Amaya-Uribe, L., Rojas, M., Azizi, G., Anaya, J. M. & Gershwin, M. E. Primary immunodeficiency and autoimmunity: a comprehensive review. J. Autoimmun. 99, 52\u201372 (2019).","journal-title":"J. Autoimmun."},{"key":"412_CR3","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1007\/s10875-021-00980-1","volume":"41","author":"SG Tangye","year":"2021","unstructured":"Tangye, S. G. et al. The ever-increasing array of novel inborn errors of immunity: an interim update by the IUIS committee. J. Clin. Immunol. 41, 666\u2013679 (2021).","journal-title":"J. Clin. Immunol."},{"key":"412_CR4","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s10875-019-00737-x","volume":"40","author":"SG Tangye","year":"2020","unstructured":"Tangye, S. G. et al. Human inborn errors of immunity: 2019 update on the classification from the International Union of Immunological Societies expert committee. J. Clin. Immunol. 40, 24\u201364 (2020).","journal-title":"J. Clin. Immunol."},{"key":"412_CR5","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1007\/s10875-017-0464-9","volume":"38","author":"C Picard","year":"2018","unstructured":"Picard, C. et al. International Union of Immunological Societies: 2017 primary immunodeficiency diseases committee report on inborn errors of immunity. J. Clin. Immunol. 38, 96\u2013128 (2018).","journal-title":"J. Clin. Immunol."},{"key":"412_CR6","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1007\/s12016-022-08933-1","volume":"63","author":"LS Raymond","year":"2022","unstructured":"Raymond, L. S., Leiding, J. & Forbes-Satter, L. R. Diagnostic modalities in primary immunodeficiency. Clin. Rev. Allergy Immunol 63, 90\u201398 (2022).","journal-title":"Clin. Rev. Allergy Immunol"},{"key":"412_CR7","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s12026-018-8996-5","volume":"66","author":"V Modell","year":"2018","unstructured":"Modell, V., Orange, J. S., Quinn, J. & Modell, F. Global report on primary immunodeficiencies: 2018 update from the Jeffrey Modell Centers Network on disease classification, regional trends, treatment modalities, and physician reported outcomes. Immunol. Res. 66, 367\u2013380 (2018).","journal-title":"Immunol. Res."},{"key":"412_CR8","doi-asserted-by":"publisher","first-page":"108931","DOI":"10.1016\/j.clim.2022.108931","volume":"236","author":"JT Anderson","year":"2022","unstructured":"Anderson, J. T., Cowan, J., Condino-Neto, A., Levy, D. & Prusty, S. Health-related quality of life in primary immunodeficiencies: impact of delayed diagnosis and treatment burden. Clin. Immunol. 236, 108931 (2022).","journal-title":"Clin. Immunol."},{"key":"412_CR9","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s12016-021-08876-z","volume":"63","author":"LJ Kobrynski","year":"2022","unstructured":"Kobrynski, L. J. Newborn screening in the diagnosis of primary immunodeficiency. Clin. Rev. Allergy Immunol. 63, 9\u201321 (2022).","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"412_CR10","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1080\/1744666X.2020.1801422","volume":"16","author":"H Abolhassani","year":"2020","unstructured":"Abolhassani, H. et al. Global systematic review of primary immunodeficiency registries. Expert Rev. Clin. Immunol. 16, 717\u2013732 (2020).","journal-title":"Expert Rev. Clin. Immunol."},{"key":"412_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10875-012-9751-7","volume":"33","author":"AA Bousfiha","year":"2013","unstructured":"Bousfiha, A. A. et al. Primary immunodeficiency diseases worldwide: more common than generally thought. J. Clin. Immunol. 33, 1\u20137 (2013).","journal-title":"J. Clin. Immunol."},{"key":"412_CR12","doi-asserted-by":"publisher","first-page":"627","DOI":"10.3389\/fimmu.2014.00627","volume":"5","author":"H Chapel","year":"2014","unstructured":"Chapel, H. et al. Primary immune deficiencies - principles of care. Front. Immunol. 5, 627 (2014).","journal-title":"Front. Immunol."},{"key":"412_CR13","doi-asserted-by":"crossref","unstructured":"Su, H. C. & Lenardo, M. J. in Stiehm\u2019s Immune Deficiencies (eds Kathleen E. Sullivan & E. Richard Stiehm) 143\u2013169 (Academic Press), (2014).","DOI":"10.1016\/B978-0-12-405546-9.00005-4"},{"key":"412_CR14","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1016\/j.jaci.2015.04.049","volume":"136","author":"FA Bonilla","year":"2015","unstructured":"Bonilla, F. A. et al. Practice parameter for the diagnosis and management of primary immunodeficiency. J. Allergy Clin. Immunol. 136, 1186\u20131205 (2015). e1181-1178.","journal-title":"J. Allergy Clin. Immunol."},{"key":"412_CR15","doi-asserted-by":"publisher","first-page":"e415","DOI":"10.1016\/S2589-7500(22)00049-8","volume":"4","author":"L Rasmy","year":"2022","unstructured":"Rasmy, L. et al. Recurrent neural network models (CovRNN) for predicting outcomes of patients with COVID-19 on admission to hospital: model development and validation using electronic health record data. Lancet. Digit Health 4, e415\u2013e425 (2022).","journal-title":"Lancet. Digit Health"},{"key":"412_CR16","doi-asserted-by":"publisher","first-page":"e482","DOI":"10.1016\/S2589-7500(22)00061-9","volume":"4","author":"S Syed","year":"2022","unstructured":"Syed, S. et al. Identifying adverse childhood experiences with electronic health records of linked mothers and children in England: a multistage development and validation study. Lancet Digit. Health 4, e482\u2013e496 (2022).","journal-title":"Lancet Digit. Health"},{"key":"412_CR17","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/s41746-022-00617-6","volume":"5","author":"N Zong","year":"2022","unstructured":"Zong, N. et al. Computational drug repurposing based on electronic health records: a scoping review. NPJ Digit. Med. 5, 77 (2022).","journal-title":"NPJ Digit. Med."},{"key":"412_CR18","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/s41746-020-0301-z","volume":"3","author":"I Landi","year":"2020","unstructured":"Landi, I. et al. Deep representation learning of electronic health records to unlock patient stratification at scale. NPJ Digit Med. 3, 96 (2020).","journal-title":"NPJ Digit Med."},{"key":"412_CR19","doi-asserted-by":"crossref","unstructured":"Cheng, H.-T. et al. Wide & deep learning for recommender systems. arXiv, 7\u201310 (2016).","DOI":"10.1145\/2988450.2988454"},{"key":"412_CR20","doi-asserted-by":"publisher","first-page":"3862","DOI":"10.1109\/TSP.2022.3192606","volume":"70","author":"Z Gao","year":"2022","unstructured":"Gao, Z., Gama, F. & Ribeiro, A. Wide and deep graph neural network with distributed online learning. IEEE Transactions Signal Proc. 70, 3862\u20133877 (2022).","journal-title":"IEEE Transactions Signal Proc."},{"key":"412_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22876-9","volume":"12","author":"A Huda","year":"2021","unstructured":"Huda, A. et al. A machine learning model for identifying patients at risk for wild-type transthyretin amyloid cardiomyopathy. Nat. Commun. 12, 2725 (2021).","journal-title":"Nat. Commun."},{"key":"412_CR22","doi-asserted-by":"publisher","unstructured":"He, K., Zhang, X., Ren, S. & Sun, J. Deep residual learning for image recognition. arXiv, 1\u201312, https:\/\/doi.org\/10.48550\/ARXIV.1512.03385 (2015).","DOI":"10.48550\/ARXIV.1512.03385"},{"key":"412_CR23","doi-asserted-by":"publisher","first-page":"e14325","DOI":"10.2196\/14325","volume":"7","author":"P Wu","year":"2019","unstructured":"Wu, P. et al. Mapping ICD-10 and ICD-10-CM codes to phecodes: workflow development and initial evaluation. JMIR Med. Inform. 7, e14325 (2019).","journal-title":"JMIR Med. Inform."},{"key":"412_CR24","doi-asserted-by":"publisher","first-page":"3002","DOI":"10.1016\/j.jaip.2022.08.041","volume":"10","author":"A Mayampurath","year":"2022","unstructured":"Mayampurath, A. et al. Early diagnosis of primary immunodeficiency disease using clinical data and machine learning. J. Allergy Clin. Immunol. Pract 10, 3002\u20133007, (2022).","journal-title":"J. Allergy Clin. Immunol. Pract"},{"key":"412_CR25","doi-asserted-by":"publisher","first-page":"e0237285","DOI":"10.1371\/journal.pone.0237285","volume":"16","author":"NL Rider","year":"2021","unstructured":"Rider, N. L. et al. PI Prob: a risk prediction and clinical guidance system for evaluating patients with recurrent infections. PLoS One 16, e0237285 (2021).","journal-title":"PLoS One"},{"key":"412_CR26","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.jaci.2021.06.008","volume":"149","author":"ML Abyazi","year":"2022","unstructured":"Abyazi, M. L. et al. Convergence of cytokine dysregulation and antibody deficiency in common variable immunodeficiency with inflammatory complications. J. Allergy Clin. Immunol. 149, 315\u2013326 e319 (2022).","journal-title":"J. Allergy Clin. Immunol."},{"key":"412_CR27","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.3389\/fimmu.2019.02009","volume":"10","author":"A Emmaneel","year":"2019","unstructured":"Emmaneel, A. et al. A computational pipeline for the diagnosis of CVID patients. Front. Immunol. 10, 2009 (2019).","journal-title":"Front. Immunol."},{"key":"412_CR28","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.clim.2018.06.011","volume":"194","author":"L Duan","year":"2018","unstructured":"Duan, L. & Grunebaum, E. Hematological malignancies associated with primary immunodeficiency disorders. Clin. Immunol. 194, 46\u201359 (2018).","journal-title":"Clin. Immunol."},{"key":"412_CR29","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1146\/annurev-med-070119-115617","volume":"72","author":"T Alexander","year":"2021","unstructured":"Alexander, T., Greco, R. & Snowden, J. A. 2021. Hematopoietic stem cell transplantation for autoimmune disease. Ann. Rev. Med. 72, 215\u2013228 (2021).","journal-title":"Ann. Rev. Med."},{"key":"412_CR30","doi-asserted-by":"publisher","first-page":"2742","DOI":"10.1182\/bloodadvances.2017010041","volume":"1","author":"JA Snowden","year":"2017","unstructured":"Snowden, J. A. et al. Evolution, trends, outcomes, and economics of hematopoietic stem cell transplantation in severe autoimmune diseases. Blood Adv. 1, 2742\u20132755 (2017).","journal-title":"Blood Adv."},{"key":"412_CR31","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1038\/s41409-019-0516-2","volume":"54","author":"RF Duarte","year":"2019","unstructured":"Duarte, R. F. et al. 2019. Indications for haematopoietic stem cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe. Bone Marrow Transplant. 54, 1525\u20131552 (2019).","journal-title":"Bone Marrow Transplant."},{"key":"412_CR32","doi-asserted-by":"publisher","unstructured":"Ballow M., S\u00e1nchez-Ram\u00f3n S., Walter J. E. Secondary Immune Deficiency and Primary Immune Deficiency Crossovers: Hematological Malignancies and Autoimmune Diseases. Front. Immunol. 13:928062, https:\/\/doi.org\/10.3389\/fimmu.2022.928062 (2022).","DOI":"10.3389\/fimmu.2022.928062"},{"key":"412_CR33","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1016\/j.anai.2013.06.013","volume":"111","author":"M Ballow","year":"2013","unstructured":"Ballow, M. Optimizing immunoglobulin treatment for patients with primary immunodeficiency disease to prevent pneumonia and infection incidence: review of the current data. Ann. Allergy. Asthma. Immunol. 111, S2\u20135, (2013).","journal-title":"Ann. Allergy. Asthma. Immunol."},{"key":"412_CR34","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1007\/s10875-022-01289-3","volume":"42","author":"SG Tangye","year":"2022","unstructured":"Tangye, S. G. et al. Human Inborn Errors of Immunity: 2022 Update on the Classification from the International Union of Immunological Societies Expert Committee. J Clin Immunol. 42, 1473\u20131507 (2022).","journal-title":"J Clin Immunol."},{"key":"412_CR35","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1007\/s10875-022-01352-z","volume":"42","author":"A Bousfiha","year":"2022","unstructured":"Bousfiha, A. et al. The 2022 Update of IUIS Phenotypical Classification for Human Inborn Errors of Immunity. J Clin Immunol. 42, 1508\u20131520 (2022).","journal-title":"J Clin Immunol."}],"container-title":["Communications Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s43856-023-00412-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-023-00412-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-023-00412-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,20]],"date-time":"2023-12-20T09:17:15Z","timestamp":1703063835000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s43856-023-00412-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,20]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["412"],"URL":"https:\/\/doi.org\/10.1038\/s43856-023-00412-8","relation":{},"ISSN":["2730-664X"],"issn-type":[{"value":"2730-664X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,20]]},"assertion":[{"value":"17 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare the following competing interests: This study was supported by Pfizer. GP, AH, GS, and DP are full-time employees of Pfizer and hold stock\/stock options. LS is a full-time employee of Immunoglobulin National Society. JR, EP, GY, DF, ND, and CW do not have any financial competing interests to declare. The authors do not have any non-financial competing interests to declare.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"189"}}